Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 19, 2014

View Archived Issues

U.S. researchers prepare new anti-B7-H5 antibodies

Biscayne Pharmaceuticals present data on novel GHRH antagonist

Ossianix extends research collaboration with Lundbeck for CNS therapeutics

Ascendis reports interim data from phase II pediatric study of TransCon Growth Hormone

Promising data presented on novel drug for the treatment of pyruvate kinase deficiency

Bone Therapeutics' phase I/IIa trial of Allob in delayed-union fractures recommended to continue

OncoSynergy forms agreement with CMC Biologics

MicroRNAs identified as potential markers of epilepsy

Antiangiogenic gene therapy evaluated in phase I/II glioblastoma study

Cardiac biomarkers have prognostic significance in coronary artery disease

Midafresa intravenous injection 0.1% for status epilepticus launched in Japan

Emergent BioSolutions acquires portfolio of broad-spectrum antibiotics

USAID awards funding to DNDi for onchocerciasis and elephantiasis

Tetraphase's eravacycline is noninferior to ertapenem in cIAI

Amunix confirms option exercise by Eli Lilly for XTEN product

Cara Therapeutics' CR-845 safe and well tolerated in patients undergoing hemodialysis

Cerulean initiates phase I/IIa trial of CRLX-301 docetaxel-bearing nanoparticles

Preclinical characterization of a novel dual orexin receptor antagonist

Bayer files BLA for BAY-81-8973 for treatment of hemophilia A

Janssen licenses recombinant hyaluronidase technology from Halozyme

Olaparib receives E.U. approval for BRCA-mutated ovarian cancer

Lilly divulges dopamine D1 receptor PAMs

Cellectis and bluebird bio report development of HIV treatment

Janssen Pharmaceutica prepares new mGlu2 receptor modulators

Abraxane approved for additional indication of unresectable pancreatic cancer in Japan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 24, 2024.
Enhanced Cognition: Lewy body dementia phase II pumps stock
BioWorld
Investors will get more details during the International Lewy Body Dementia Conference in Amsterdam late next month, but Wall Street is already buzzing about...
Experimental mRNA gene therapy suppresses preeclampsia in mice
BioWorld MedTech
A gene therapy based on an enhanced lipid nanoparticle (LNP) loaded with vascular endothelial growth factor (VEGF) mRNA could be developed for the treatment of...
Drug duo to Repare lack in gyno cancers? Phase I shows promise
BioWorld
Wall Street wasn’t jumping up and down about Repare Therapeutics Inc.’s early data in gynecological cancers, though the findings look positive and the company has...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.